company background image
SPPI logo

Spectrum Pharmaceuticals NasdaqCM:SPPI Rapport sur les actions

Dernier prix

US$1.03

Capitalisation boursière

US$209.9m

7D

5.3%

1Y

17.0%

Mise à jour

02 Aug, 2023

Données

Finances de l'entreprise +

Spectrum Pharmaceuticals, Inc.

NasdaqCM:SPPI Rapport sur les actions

Capitalisation boursière : US$209.9m

Spectrum Pharmaceuticals, Inc. Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Spectrum Pharmaceuticals
Historique des cours de bourse
Prix actuel de l'actionUS$1.03
Plus haut sur 52 semainesUS$1.57
Plus bas sur 52 semainesUS$0.32
Bêta2.14
1Variation sur 1 mois4.54%
Variation sur 3 mois-1.90%
Variation sur 1 an17.05%
3Variation sur 3 ans-71.39%
Variation sur 5 ans-95.10%
Évolution depuis l'introduction en bourse-99.25%

Nouvelles et mises à jour récentes

Recent updates

Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts

May 14
Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts

Earnings Update: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Just Reported And Analysts Are Boosting Their Estimates

May 12
Earnings Update: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Just Reported And Analysts Are Boosting Their Estimates

Spectrum plunges 28% after FDA scientists question poziotinib evidence for NSCLC

Sep 20

Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?

Sep 16
Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?

Spectrum Pharmaceuticals stock jumps 10% afterhours on FDA nod for Rolvedon injection

Sep 09

Spectrum Pharmaceuticals: Revisiting This 'Soap Opera'

Aug 21

Spectrum Pharmaceuticals Q2 2022 Earnings Preview

Aug 10

Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Jun 04
Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Spectrum Pharmaceuticals: Some Last Words

Feb 25

Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Oct 05
Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Spectrum Pharmaceuticals' CRL: There Is Very Little Clarity

Aug 12

Spectrum's Big Approval: Any Day Now

Jul 29

FDA initiates pre-approval inspection for Spectrum pharmaceuticals' ROLONTIS

Jun 01

Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

May 31
Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

We're Keeping An Eye On Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Rate

Feb 12
We're Keeping An Eye On Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Rate

Spectrum Pharma drops after announcing less-than-favorable Phase 2 data

Dec 22

Here's What Spectrum Pharmaceuticals, Inc.'s (NASDAQ:SPPI) Shareholder Ownership Structure Looks Like

Dec 21
Here's What Spectrum Pharmaceuticals, Inc.'s (NASDAQ:SPPI) Shareholder Ownership Structure Looks Like

Spectrum Pharma Is Down But Not Out

Nov 16

Spectrum Shareholders In Limbo As FDA Delays Rolontis Decision Date, Agrees To Discuss Poziotinib

Nov 11

Rendement pour les actionnaires

SPPIUS BiotechsUS Marché
7D5.3%-0.7%-1.6%
1Y17.0%19.8%30.8%

Rendement vs Industrie: SPPI exceeded the US Biotechs industry which returned -4.2% over the past year.

Rendement vs marché: SPPI exceeded the US Market which returned 14.1% over the past year.

Volatilité des prix

Is SPPI's price volatile compared to industry and market?
SPPI volatility
SPPI Average Weekly Movement7.2%
Biotechs Industry Average Movement9.6%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

Cours de l'action stable: SPPI's share price has been volatile over the past 3 months.

Volatilité au fil du temps: SPPI's weekly volatility has decreased from 15% to 7% over the past year.

À propos de l'entreprise

FondéeSalariésPDGSite web
198786Tom Rigawww.sppirx.com

Spectrum Pharmaceuticals, Inc. Résumé des fondamentaux

Comment les bénéfices et les revenus de Spectrum Pharmaceuticals se comparent-ils à sa capitalisation boursière ?
SPPI statistiques fondamentales
Capitalisation boursièreUS$209.89m
Bénéfices(TTM)-US$67.71m
Recettes(TTM)US$25.73m

8.2x

Ratio P/S

-3.1x

Ratio P/E

Le site SPPI est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
SPPI compte de résultat (TTM)
RecettesUS$25.73m
Coût des recettesUS$2.86m
Marge bruteUS$22.87m
Autres dépensesUS$90.58m
Les revenus-US$67.71m

Derniers bénéfices déclarés

Mar 31, 2023

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)-0.33
Marge brute88.90%
Marge bénéficiaire nette-263.16%
Ratio dettes/capitaux propres107.6%

Quelles ont été les performances à long terme de SPPI?

Voir les performances historiques et les comparaisons